Regeneron Pharmaceuticals' Interest & Investment Income fell 11492.17% to -$6.0 million in Q4 2017 from the same period last year, while for Dec 2017 it was -$25.1 million, marking a year-over-year decrease of 24911.74%. This contributed to the annual value of -$25.1 million for FY2017, which is 24911.74% down from last year.
Latest data reveals that Regeneron Pharmaceuticals reported Interest & Investment Income of -$6.0 million as of Q4 2017, which was down 11492.17% from -$6.2 million recorded in Q3 2017.
In the past 5 years, Regeneron Pharmaceuticals' Interest & Investment Income ranged from a high of $2.1 million in Q3 2015 and a low of -$18.2 million during Q4 2015
Over the past 5 years, Regeneron Pharmaceuticals' median Interest & Investment Income value was -$873500.0 (recorded in 2016), while the average stood at -$2.5 million.
As far as peak fluctuations go, Regeneron Pharmaceuticals' Interest & Investment Income skyrocketed by 10548.25% in 2014, and later crashed by 156666.67% in 2016.
Quarter analysis of 5 years shows Regeneron Pharmaceuticals' Interest & Investment Income stood at -$2.3 million in 2013, then skyrocketed by 174.24% to $1.7 million in 2014, then plummeted by 1186.11% to -$18.2 million in 2015, then surged by 84.58% to -$2.8 million in 2016, then plummeted by 114.92% to -$6.0 million in 2017.
Its Interest & Investment Income was -$6.0 million in Q4 2017, compared to -$6.2 million in Q3 2017 and -$5.4 million in Q2 2017.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value